LEFT VENTRICULAR DYSFUNCTION
Clinical trials for LEFT VENTRICULAR DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new LEFT VENTRICULAR DYSFUNCTION trials appear
Sign up with your email to follow new studies for LEFT VENTRICULAR DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart pump may boost survival in High-Risk surgery patients
Disease control OngoingThis study tests whether using the Impella 5.5 heart pump during and after heart surgery improves outcomes for 100 patients with severely weakened hearts. The pump supports blood flow, aiming to reduce death, stroke, kidney failure, and heart failure after surgery. Participants m…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Heart stem cell trial pulled before it even started
Disease control TerminatedThis trial aimed to test whether umbilical cord stem cells, delivered through a catheter into heart arteries, could safely improve heart function in people with severe heart damage after a major heart attack. It was designed for patients with very weak hearts (ejection fraction b…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Heart pump may boost survival in complex stenting
Disease control OngoingThis study tests whether using the Impella heart pump during a high-risk stenting procedure helps people with weak hearts and blocked arteries. About 1,250 participants will be randomly assigned to get either Impella-supported stenting or standard care. The goal is to see if the …
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for long COVID heart sufferers: drug combo trial launches
Disease control OngoingThis study tests whether a combination of anti-inflammatory and heart-protecting drugs can reduce symptoms and heart damage in people with Long COVID who have ongoing heart inflammation. About 279 adults with heart inflammation seen on MRI will receive either the drug combo or a …
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New heart pump may reduce death and stroke in risky surgeries
Disease control OngoingThis study tests the Impella 5.5 heart pump in 123 high-risk patients with weak hearts (ejection fraction 25% or less) who need complex cardiac surgery. The pump supports the heart during and after surgery to prevent failure, stroke, and other complications. The goal is to confir…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can simple blood tests and ECGs predict sudden cardiac arrest?
Knowledge-focused OngoingThis study follows over 5,700 people with coronary artery disease and mild heart damage to see if blood tests and ECGs can better predict who is at risk for sudden cardiac death. The goal is to find inexpensive markers that could help doctors decide who needs a defibrillator. Par…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC